Members of the National Association of Letter Carriers overwhelmingly voted down a tentative agreement for a new contract earlier this month.

BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...

Through this dialogue, we will strive to attain higher levels of social cohesion and develop a common programme to pursue our ...